← FDA Drug Approvals (Drugs@FDA)

BESIVANCE

NDA · New Drug Application · Sponsor: BAUSCH AND LOMB · Approved 2009-05-28

Drug application

FDA Application #

NDA022308

Application type

New Drug Application

Brand name

BESIVANCE

Generic name

BESIFLOXACIN

Active ingredients

BESIFLOXACIN HYDROCHLORIDE

Dosage form

SUSPENSION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

BAUSCH AND LOMB

Manufacturer

Bausch & Lomb Americas Inc.

First approval

2009-05-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown